Trademark: 97077402
Word
CIMPLRX
Status Date
Monday, September 9, 2024
Filing Date
Friday, October 15, 2021
Published for Opposition
Tuesday, October 15, 2024
9 Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software
42 New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network
Oct 19, 2021
New Application Entered
Nov 4, 2021
New Application Office Supplied Data Entered
Jul 21, 2022
Assigned To Examiner
Jul 26, 2022
Non-Final Action Written
Jul 26, 2022
Non-Final Action E-Mailed
Jan 26, 2023
Teas/Email Correspondence Entered
Jul 26, 2022
Notification Of Non-Final Action E-Mailed
Jan 25, 2023
Teas Response To Office Action Received
Jan 25, 2023
Correspondence Received In Law Office
Feb 21, 2023
Suspension Letter Written
Feb 21, 2023
Letter Of Suspension E-Mailed
Feb 21, 2023
Notification Of Letter Of Suspension E-Mailed
Sep 7, 2023
Teas Response To Suspension Inquiry Received
Sep 7, 2023
Suspension Inquiry Written
Sep 7, 2023
Inquiry To Suspension E-Mailed
Sep 7, 2023
Notification Of Inquiry As To Suspension E-Mailed
Jan 26, 2024
Assigned To Lie
Jan 26, 2024
Correspondence Received In Law Office
Jan 26, 2024
Teas/Email Correspondence Entered
Feb 13, 2024
Approved For Pub - Principal Register
Feb 16, 2024
On Hold - Electronic Record Review Required
Trademark Alertz updated from USPTO on 2030-01-24
